What is CADASIL? (Definition)
(Symptoms, Causes & Treatment)
According to the U.S. National Library of Medicine, Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, also called CADASIL, is an inherited condition which causes stroke and other impairments. This condition affects blood flow in small blood vessels, particularly cerebral vessels within the brain. The muscle cells surrounding these blood vessels (vascular smooth muscle cells) are abnormal and gradually die. In the brain, the resulting blood vessel damage (arteriopathy) can cause migraines, often with visual sensations or auras, or recurrent seizures (epilepsy).
See below for updated news and information regarding CADASIL including new medical research, treatment options and advancements.
Latest CADASIL Research – Treatment News, Discoveries and Findings
No recent news regarding CADASIL is available.
Clinical Resources: Treatment Therapies & Guidelines
Oxford University Press – Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients
Clinical Trials – Investigational Therapies
For information on current clinical trials, visit www.clinicaltrials.gov. This is a searchable registry and results database of federally and privately supported clinical trials taking place in the U.S and abroad. ClinicalTrials.gov provides information about a trial’s purpose, who may participate, locations, and phone numbers. This information should be used in conjunction with advice from health care professionals.
For information about clinical trials being conducted at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Toll Free: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials conducted in Europe, visit: https://www.clinicaltrialsregister.eu/ctr-search/search
If you have experience dealing with this disease or condition (especially with regard to symptoms, diagnosis, causes or treatment), please share below: